Healthcare - Biotechnology - NASDAQ - US
$ 0.744
-3.7 %
$ 85.7 M
Market Cap
-8.27
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
11.87%
EBIT
Estimate
6.20%
Net Income
Estimate
44.77%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Coherus BioSciences, Inc.
CHRS has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart CHRS
EBIT FORECAST
EBIT Forecast Chart CHRS
NET INCOME FORECAST
Net Income Chart CHRS